U.S. FDA commissioner to testify about infant formula before House panel next week

1 min read
FDA Commissioner nominee Califf testifies at nomination hearing in Washington

(Reuters) – U.S. Food and Drug Administration Commissioner Robert Califf is set to testify before the House Appropriations Committee on May 19 his agency’s resposne to an infant formula shortage in the country, the panel said Thursday.

(Reporting by Tyler Clifford; Editing by Doina Chiacu)


Breaking News
FDA Finds No Evidence of Bacteria at Shuttered Baby Formula Facility that Sparked Crisis